Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Cardiology

Living with KSS: Managing Your Heart and Health

At a Glance

Managing Kearns-Sayre syndrome (KSS) requires proactive, multidisciplinary care to prevent life-threatening complications. The most critical priority is monitoring the heart for sudden electrical block, which often requires a preventative pacemaker.

Managing Kearns-Sayre Syndrome (KSS) focuses on two main goals: preventing life-threatening complications and managing symptoms to improve your quality of life [1][2]. Because KSS is a multisystem condition, your care will involve a team of specialists working together to monitor “high-energy” organs like the heart, glands, and eyes [3][4].

The Heart: The Most Critical Priority

The most significant health risk in KSS is a disruption of the heart’s electrical system, known as cardiac conduction disease [5][6]. This can lead to heart block, where electrical signals move too slowly or stop entirely, which can cause sudden heart failure [6][7].

  • Unpredictable Progression: Heart block in KSS can progress very quickly and without warning [5][8].
  • Prophylactic Pacemakers: Because the risk is so high, many doctors recommend a “prophylactic” (preventative) permanent pacemaker even if you don’t have symptoms like fainting yet [6][8].
  • ICDs: If your doctor detects high-risk heart rhythms (arrhythmias), they may recommend an implantable cardioverter-defibrillator (ICD), which can provide a life-saving shock for dangerous, rapid heart rhythms (like ventricular fibrillation) to prevent sudden cardiac death [5][7].
  • Medical Alert Bracelet: Given the sudden risk of heart block, it is highly recommended to wear a medical alert bracelet stating you have KSS and are at risk for cardiac conduction block.

Managing Endocrine and Systemic Signs

Mitochondrial dysfunction can affect the glands that produce hormones. These issues are usually treated with standard replacement therapies:

  • Diabetes: If the pancreas does not produce enough insulin, it is managed with insulin therapy and diet, similar to Type 1 diabetes [9][4].
  • Hypoparathyroidism: This occurs when glands in the neck don’t regulate calcium correctly. It is managed with calcium and Vitamin D supplements to prevent muscle cramps and seizures [10][4].
  • Growth Issues: Some patients may receive growth hormone if KSS has affected their height or development [9].

Eye and Vision Care

  • Ptosis Surgery: If drooping eyelids interfere with vision or cause neck pain from tilting your head back, a surgeon can “lift” the lids [11]. However, these surgeries must be done carefully to ensure the eye can still close properly during sleep [12]. If the eye stays open, you are at risk for exposure keratopathy, a painful condition where the cornea becomes dry and damaged.
  • Retinopathy: While there is no direct treatment for the pigment changes in the retina, regular exams are necessary to watch for rare complications like swelling or abnormal blood vessel growth [13].

Medications, Supplements, and Safety

Critical Safety Warnings

  • Anesthesia Safety: General anesthesia can be extremely dangerous for patients with mitochondrial diseases. You must alert your surgical team and anesthesiologist about your KSS diagnosis prior to any procedure.
  • Medication Contraindications: Certain everyday medications and antibiotics (like aminoglycosides or valproic acid) can be toxic to mitochondria or worsen muscle weakness. Have your lead mitochondrial specialist review all new prescriptions.

The Role of “Mito-Cocktails” and Folinic Acid

  • Folinic Acid (Leucovorin): Patients with KSS are at a high risk for cerebral folate deficiency, which can cause severe, progressive neurological damage (leukoencephalopathy). Unlike general mitochondrial supplements, folinic acid is a targeted, standard-of-care treatment that can prevent or even reverse this decline [14][15].
  • Other Supplements: Many patients are prescribed a “mito-cocktail,” which often includes Coenzyme Q10 (CoQ10) or Idebenone [16][9]. While these are generally safe and used to support mitochondrial function, there is currently no strong clinical trial evidence proving they can “cure” or significantly stop the progression of KSS [16][9].

Currently, there is no cure for KSS, but proactive management—especially of the heart and neurological system—is the most effective way to protect your long-term health [2][6].

Common questions in this guide

Why do KSS patients often need a pacemaker?
Kearns-Sayre syndrome can cause sudden and unpredictable heart block, where the heart's electrical signals slow down or stop. Doctors often recommend a preventative pacemaker to protect against this life-threatening complication, even before symptoms like fainting occur.
Is general anesthesia safe for patients with Kearns-Sayre syndrome?
General anesthesia can be extremely dangerous for individuals with mitochondrial diseases like KSS. It is critical to alert your surgical and anesthesia teams about your diagnosis prior to any procedure so they can take appropriate safety measures.
Why is folinic acid prescribed for Kearns-Sayre syndrome?
Patients with KSS are at high risk for cerebral folate deficiency, which can cause severe neurological damage. Folinic acid is a targeted, standard-of-care treatment that can help prevent or even reverse this neurological decline.
What are the risks of ptosis (drooping eyelid) surgery with KSS?
Lifting drooping eyelids must be done carefully to ensure the eyes can still close fully during sleep. If they remain slightly open, patients can develop a painful condition called exposure keratopathy, where the cornea becomes dry and damaged.
Do mitochondrial supplements or mito-cocktails cure KSS?
While supplements like Coenzyme Q10 are often prescribed to support cellular energy, there is currently no strong clinical evidence that they stop the progression of or cure Kearns-Sayre syndrome.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my most recent EKG show any signs of 'fascicular block' that would make me a candidate for a prophylactic pacemaker?
  2. 2.If you are recommending an ICD instead of a standard pacemaker, what specific high-risk features did you identify in my heart rhythm?
  3. 3.How frequently should we be testing my blood glucose and calcium levels to monitor for endocrine complications?
  4. 4.If I consider ptosis surgery, how do we ensure my eyes stay hydrated and protected from scratches (exposure keratopathy) afterward?
  5. 5.What is your specific recommendation for Folinic acid or a 'mito-cocktail' (like CoQ10), and how will we know if it is helping?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Kearns-Sayre syndrome: Two case reports and a review for the primary care physician.

    Richmond C, Powell L, Brittingham ZD, Mancuso A

    Journal of family medicine and primary care 2023; (12(4)):792-795 doi:10.4103/jfmpc.jfmpc_1790_22.

    PMID: 37312792
  2. 2

    Propofol and Kearns-Sayre Syndrome: An idiographic approach.

    Maddali MM, Munasinghe TD, Al Aamri I, et al.

    Sultan Qaboos University medical journal 2023; (23(Spec Iss)):63-67 doi:10.18295/squmj.12.2023.080.

    PMID: 38161763
  3. 3

    Recognizing the evolution of clinical syndrome spectrum progression in individuals with single large-scale mitochondrial DNA deletion syndromes (SLSMDS).

    Ganetzky R, Stanley KD, MacMullen LE, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2025; (27(5)):101386 doi:10.1016/j.gim.2025.101386.

    PMID: 39985363
  4. 4

    Fatal pneumonia in a patient with Kearns-Sayre syndrome case report and literature review.

    Zhang J, Song Z, Zhou H, et al.

    Frontiers in medicine 2025; (12()):1575384 doi:10.3389/fmed.2025.1575384.

    PMID: 40823579
  5. 5

    Progressive Conduction Disease in a Mitochondrial Disorder.

    Amaro T, Bueno S, Guirão C, et al.

    JACC. Case reports 2026; 107749 doi:10.1016/j.jaccas.2026.107749.

    PMID: 42171571
  6. 6

    Prophylactic pacemaker placement at first signs of conduction disease in Kearns-Sayre syndrome.

    Trivedi M, Goldstein A, Arora G

    Cardiology in the young 2018; (28(12)):1487-1488 doi:10.1017/S1047951118001609.

    PMID: 30326976
  7. 7

    The necessity of implantable cardioverter defibrillators in patients with Kearns-Sayre syndrome - systematic review of the articles.

    Imamura T, Sumitomo N, Muraji S, et al.

    International journal of cardiology 2019; (279()):105-111 doi:10.1016/j.ijcard.2018.12.064.

    PMID: 30642644
  8. 8

    Progressive involvement of cardiac conduction system in paediatric patients with Kearns-Sayre syndrome: how to predict occurrence of complete heart block and sudden cardiac death?

    Di Mambro C, Tamborrino PP, Silvetti MS, et al.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2021; (23(6)):948-957 doi:10.1093/europace/euaa335.

    PMID: 33336258
  9. 9

    A case of hypopituitarism accompanying Kearns-Sayre syndrome treated with human chorionic gonadotropin: A case report and literature review.

    Kang YX, Wang YJ, Zhang Q, et al.

    Andrologia 2017; (49(8)) doi:10.1111/and.12711.

    PMID: 27709644
  10. 10

    Nutritional issues in a diabetic patient with Kearns-Sayre syndrome.

    Szwilling A, Dzygalo K, Nowaczyk J

    Endocrinology, diabetes & metabolism case reports 2020; (2020()).

    PMID: 33434157
  11. 11

    Management of Ptosis in Kearns-Sayre Syndrome: A Case Report and Literature Review.

    Moustaine MO, Azemour Z, Mohammed F, et al.

    Archives of plastic surgery 2024; (51(2)):182-186 doi:10.1055/a-2207-7587.

    PMID: 38596148
  12. 12

    Teaching NeuroImages: Kearns-Sayre syndrome.

    Nguyen MTB, Micieli J, Margolin E

    Neurology 2019; (92(5)):e519-e520 doi:10.1212/WNL.0000000000006861.

    PMID: 30635486
  13. 13

    Anti-VEGF therapy for proliferative diabetic retinopathy in Kearns-Sayre syndrome.

    Leung V, Wong JG, Grigg JR

    Documenta ophthalmologica. Advances in ophthalmology 2025; (150(1)):41-46 doi:10.1007/s10633-024-09999-2.

    PMID: 39729257
  14. 14

    Kearns-Sayre syndrome presenting with fanconi syndrome: a case report.

    Lu Y, Jian S, Qian M, et al.

    Translational pediatrics 2025; (14(5)):1059-1064 doi:10.21037/tp-2025-138.

    PMID: 40519735
  15. 15

    Increased Sphingomyelin and Free Sialic Acid in Cerebrospinal Fluid of Kearns-Sayre Syndrome: New Findings Using Untargeted Metabolomics.

    Salvador CL, Oppebøen M, Vassli AØ, et al.

    Pediatric neurology 2023; (143()):68-76 doi:10.1016/j.pediatrneurol.2023.02.016.

    PMID: 37018879
  16. 16

    Corneal Involvement in Kearns-Sayre Syndrome Responsive to Coenzyme-Q?

    Finsterer J, Zarrouk-Mahjoub S

    Cornea 2016; (35(12)):e39 doi:10.1097/ICO.0000000000001043.

    PMID: 27741019

This page provides educational information on managing Kearns-Sayre syndrome. Always consult your multidisciplinary medical team before starting supplements or considering surgical interventions.

Get notified when new evidence is published on Kearns-Sayre syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.